32.50.Z - Manufacture of medical and dental instruments and supplies
46.18.Z - Agents specialised in the sale of other particular products
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
70.22.Z - Business and other management consultancy activities
71.12.Z - Engineering activities and related technical consultancy
72.19.Z - Other research and experimental development on natural sciences and engineering
74.10.Z - Specialised design activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,7 | 50,2 | ||
Gross profit (loss) | 0,8 | 0,3 | 0,6 | 106,3 |
EBITDA | 0,7 | 0,3 | 0,6 | 109,2 |
Short time liabilities | 0 | 0 | 0 | 568,3 |
Other operating costs | 0 | 0 | ||
Equity capital | 1,2 | 1,4 | 1,9 | 36 |
Operating profit (EBIT) | 0,7 | 0,3 | 0,6 | 101,3 |
Assets | 1,5 | 1,9 | 3,6 | 88 |
Net profit (loss) | 0,7 | 0,2 | 0,5 | 106,3 |
Cash | 1 | 1,7 | 1,7 | 0,7 |
Net income from sale | 1,1 | 1,6 | 1,9 | 19,4 |
Liabilities and provisions for liabilities | 0,3 | 0,5 | 1,7 | 234,2 |
Working assets | 1,4 | 1,7 | 3,5 | 98,7 |
Other income costs | 0 | -100 | ||
Depreciation | 0 | 0 | 0 | 500 |
% | % | % | p.p. | |
Profitability of capital | 61,5 | 17,4 | 26,5 | 9,1 |
Equity capital to total assets | 80,7 | 73,7 | 53,3 | -20,4 |
Gross profit margin | 72,6 | 17,3 | 29,9 | 12,6 |
EBITDA Margin | 69,6 | 18,1 | 31,7 | 13,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 14 | 1 | 3 | 2 |
Current financial liquidity indicator | 34.4487190246582 | 699.0079956054688 | 207.86277770996094 | -491,1 |
Net dept to EBITDA | -1.0590291023254395 | -4.046019554138184 | 0.011270861141383648 | 4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane